183 related articles for article (PubMed ID: 24560446)
1. Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
Stricker TP; Morales La Madrid A; Chlenski A; Guerrero L; Salwen HR; Gosiengfiao Y; Perlman EJ; Furman W; Bahrami A; Shohet JM; Zage PE; Hicks MJ; Shimada H; Suganuma R; Park JR; So S; London WB; Pytel P; Maclean KH; Cohn SL
Mol Oncol; 2014 May; 8(3):669-78. PubMed ID: 24560446
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer.
Omolo B; Yang M; Lo FY; Schell MJ; Austin S; Howard K; Madan A; Yeatman TJ
BMC Med Genomics; 2016 Oct; 9(1):65. PubMed ID: 27756306
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
[TBL] [Abstract][Full Text] [Related]
4. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
De Preter K; Mestdagh P; Vermeulen J; Zeka F; Naranjo A; Bray I; Castel V; Chen C; Drozynska E; Eggert A; Hogarty MD; Izycka-Swieszewska E; London WB; Noguera R; Piqueras M; Bryan K; Schowe B; van Sluis P; Molenaar JJ; Schramm A; Schulte JH; Stallings RL; Versteeg R; Laureys G; Van Roy N; Speleman F; Vandesompele J
Clin Cancer Res; 2011 Dec; 17(24):7684-92. PubMed ID: 22031095
[TBL] [Abstract][Full Text] [Related]
5. Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
Pinto N; Mayfield JR; Raca G; Applebaum MA; Chlenski A; Sukhanova M; Bagatell R; Irwin MS; Little A; Rawwas J; Gosiengfiao Y; Delattre O; Janoueix-Lerosey I; Lapouble E; Schleiermacher G; Cohn SL
Pediatr Blood Cancer; 2016 Jun; 63(6):1019-23. PubMed ID: 26864375
[TBL] [Abstract][Full Text] [Related]
6. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
[TBL] [Abstract][Full Text] [Related]
7. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
[TBL] [Abstract][Full Text] [Related]
8. mRNA transcript quantification in archival samples using multiplexed, color-coded probes.
Reis PP; Waldron L; Goswami RS; Xu W; Xuan Y; Perez-Ordonez B; Gullane P; Irish J; Jurisica I; Kamel-Reid S
BMC Biotechnol; 2011 May; 11():46. PubMed ID: 21549012
[TBL] [Abstract][Full Text] [Related]
9. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
[TBL] [Abstract][Full Text] [Related]
10. Comparison of skin biopsy sample processing and storage methods on high dimensional immune gene expression using the Nanostring nCounter system.
Vider J; Croaker A; Cox AJ; Raymond E; Rogers R; Adamson S; Doyle M; O'Brien B; Cripps AW; West NP
Diagn Pathol; 2020 May; 15(1):57. PubMed ID: 32414387
[TBL] [Abstract][Full Text] [Related]
11. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
Vermeulen J; De Preter K; Naranjo A; Vercruysse L; Van Roy N; Hellemans J; Swerts K; Bravo S; Scaruffi P; Tonini GP; De Bernardi B; Noguera R; Piqueras M; Cañete A; Castel V; Janoueix-Lerosey I; Delattre O; Schleiermacher G; Michon J; Combaret V; Fischer M; Oberthuer A; Ambros PF; Beiske K; Bénard J; Marques B; Rubie H; Kohler J; Pötschger U; Ladenstein R; Hogarty MD; McGrady P; London WB; Laureys G; Speleman F; Vandesompele J
Lancet Oncol; 2009 Jul; 10(7):663-71. PubMed ID: 19515614
[TBL] [Abstract][Full Text] [Related]
12. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.
Xie Y; Xiao G; Coombes KR; Behrens C; Solis LM; Raso G; Girard L; Erickson HS; Roth J; Heymach JV; Moran C; Danenberg K; Minna JD; Wistuba II
Clin Cancer Res; 2011 Sep; 17(17):5705-14. PubMed ID: 21742808
[TBL] [Abstract][Full Text] [Related]
13. Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.
Cangelosi D; Muselli M; Parodi S; Blengio F; Becherini P; Versteeg R; Conte M; Varesio L
BMC Bioinformatics; 2014; 15 Suppl 5(Suppl 5):S4. PubMed ID: 25078098
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
[TBL] [Abstract][Full Text] [Related]
15. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
Tomioka N; Oba S; Ohira M; Misra A; Fridlyand J; Ishii S; Nakamura Y; Isogai E; Hirata T; Yoshida Y; Todo S; Kaneko Y; Albertson DG; Pinkel D; Feuerstein BG; Nakagawara A
Oncogene; 2008 Jan; 27(4):441-9. PubMed ID: 17637744
[TBL] [Abstract][Full Text] [Related]
16. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
17. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
[TBL] [Abstract][Full Text] [Related]
18. 72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues.
Nishio M; Naoi Y; Tsunashima R; Nakauchi C; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Clin Breast Cancer; 2014 Jun; 14(3):e73-80. PubMed ID: 24461457
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
Meng X; Feng C; Fang E; Feng J; Zhao X
J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.
Abramovitz M; Barwick BG; Willis S; Young B; Catzavelos C; Li Z; Kodani M; Tang W; Bouzyk M; Moreno CS; Leyland-Jones B
Br J Cancer; 2011 Nov; 105(10):1574-81. PubMed ID: 22067903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
